Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mazyar Shadman

Showing results (61-70 of 224) with videos related to

Pageof 23
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2019
Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of LifeGeorge E Georges, Merav Bar, Lynn Onstad, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 10, 2018
Modified VR-CAP, Alternating With Rituximab and High-dose Cytarabine: An Effective Pre-transplant Induction Regimen for Mantle Cell LymphomaStephen D Smith, Shruti Gandhy, Ajay K Gopal, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 29, 2010
Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polypsKaren J Wernli, Polly A Newcomb, Yinghui Wang, et al.
Leukemia & Lymphoma|October 3, 2018
A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off studySarah A Buckley, Mary-Elizabeth Percival, Megan Othus, et al.
Blood Cancer Journal|May 2, 2024
Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparisonMazyar Shadman, Alessandra Tedeschi, Leyla Mohseninejad, et al.
Therapeutic Advances in Medical Oncology|July 14, 2025
Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC)Mazyar Shadman, Jennifer R Brown, Rhys Williams, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 7, 2025
Perspectives on Current Challenges and Emerging Approaches for Lymphoma Management From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma ConferenceAlexey V Danilov, Craig Sauter, Tycel Phillips, et al.
Cancer Research|September 28, 2014
In vivo localization of ⁹⁰Y and ¹⁷⁷Lu radioimmunoconjugates using Cerenkov luminescence imaging in a disseminated murine leukemia modelEthan R Balkin, Aimee Kenoyer, Johnnie J Orozco, et al.
Blood Neoplasia|June 23, 2025
Real-world characteristics, treatment patterns, and outcomes of patients with 2 or more LOTs for CLL/SLL in the United StatesMatthew S Davids, Jacob Ambrose, Enrico de Nigris, et al.
British Journal of Haematology|October 14, 2009
Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemiaThomas R Chauncey, Holly Gundacker, Mazyar Shadman, et al.
Pageof 23

Showing results (61-70 of 224) with videos related to

Sort By:
Pageof 23
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2019
Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of LifeGeorge E Georges, Merav Bar, Lynn Onstad, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 10, 2018
Modified VR-CAP, Alternating With Rituximab and High-dose Cytarabine: An Effective Pre-transplant Induction Regimen for Mantle Cell LymphomaStephen D Smith, Shruti Gandhy, Ajay K Gopal, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 29, 2010
Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polypsKaren J Wernli, Polly A Newcomb, Yinghui Wang, et al.
Leukemia & Lymphoma|October 3, 2018
A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off studySarah A Buckley, Mary-Elizabeth Percival, Megan Othus, et al.
Blood Cancer Journal|May 2, 2024
Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparisonMazyar Shadman, Alessandra Tedeschi, Leyla Mohseninejad, et al.
Therapeutic Advances in Medical Oncology|July 14, 2025
Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC)Mazyar Shadman, Jennifer R Brown, Rhys Williams, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 7, 2025
Perspectives on Current Challenges and Emerging Approaches for Lymphoma Management From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma ConferenceAlexey V Danilov, Craig Sauter, Tycel Phillips, et al.
Cancer Research|September 28, 2014
In vivo localization of ⁹⁰Y and ¹⁷⁷Lu radioimmunoconjugates using Cerenkov luminescence imaging in a disseminated murine leukemia modelEthan R Balkin, Aimee Kenoyer, Johnnie J Orozco, et al.
Blood Neoplasia|June 23, 2025
Real-world characteristics, treatment patterns, and outcomes of patients with 2 or more LOTs for CLL/SLL in the United StatesMatthew S Davids, Jacob Ambrose, Enrico de Nigris, et al.
British Journal of Haematology|October 14, 2009
Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemiaThomas R Chauncey, Holly Gundacker, Mazyar Shadman, et al.
Pageof 23